Feasibility randomised multicentre, double-blind, double-dummy controlled trial of anakinra, an interleukin-1 receptor antagonist versus intramuscular methylprednisolone for acute gout attacks in patients with chronic kidney disease (ASGARD): protocol study

INTRODUCTION: Acute gout occurs in people with chronic kidney disease, who are commonly older people with comorbidities such as hypertension, heart disease and diabetes. Potentially harmful treatments are administered to these vulnerable patients due to a lack of clear evidence. Newly available trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Balasubramaniam, Gowrie, Parker, Trisha, Turner, David, Parker, Mike, Scales, Jonathan, Harnett, Patrick, Harrison, Michael, Ahmed, Khalid, Bhagat, Sweta, Marianayagam, Thiraupathy, Pitzalis, Costantino, Mallen, Christian, Roddy, Edward, Almond, Mike, Dasgupta, Bhaskar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588981/
https://www.ncbi.nlm.nih.gov/pubmed/28877949
http://dx.doi.org/10.1136/bmjopen-2017-017121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588981/
https://www.ncbi.nlm.nih.gov/pubmed/28877949
http://dx.doi.org/10.1136/bmjopen-2017-017121

Ejemplares similares